BDA 1.06% 46.5¢ bod australia limited

Ann: API to stock full Bod portfolio of natural medicines, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 225 Posts.
    lightbulb Created with Sketch. 15
    Ket points:
    • API, one of Australia’s largest pharmacy wholesalers, to stock Bod’s entire natural medicines range – including new products, SediStress and Enterofytol
    • Products have now been classed as part of API’s ‘core range’ which allows for better market positioning, improved working capital management and centralised deliveries
    • Company has also launched new pack sizes for brands to secure additional ‘on shelf’ presence
    • Company to work with API to promote products through its network of ~2,000 pharmacies including Priceline, Chemsave and Pharmacy 4 Less – allowing accelerated penetration and broader distribution footprint
    • All brands to be live in API’s system by mid-April – sales expected shortly thereafter. SediStress to follow in July
    • Discussions progressing well with other leading wholesalers to drive growth – additional agreements expected near term
    Well done BDA - another solid development!
 
watchlist Created with Sketch. Add BDA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.